Latest Sick sinus syndrome Stories

2013-06-26 16:41:42

PREFER AF shows European clinicians adhere well to AF guidelines Two important studies were released at the Late Breaking Clinical Trials session II at EHRA EUROPACE 2013. The PREFER AF study2 found that Oral anticoagulation is now used in over 85% of patients with atrial fibrillation (AF) eligible for therapy. And ISSUE (the International Study on Syncope of Uncertain Aetiology) determined that cardiac pacing is more effective in patients with presumed neurally mediated syncope (NMS) and...

2011-12-07 14:33:30

Loyola physician co-authors study of devices donated to poor patients in India Many heart patients in India are too poor to afford pacemakers. But a study has found that removing pacemakers from deceased Americans, resterilizing the devices and implanting them in Indian patients "is very safe and effective." Dr. Gaurav Kulkarni of Loyola University Medical Center is a co-author of the study, published online ahead of print in the American Journal of Cardiology. Kulkarni helped conduct...

2011-03-06 12:09:00

REYKJAVIK, Iceland, March 6, 2011 /PRNewswire-FirstCall/ -- Scientists at deCODE genetics and academic colleagues from Iceland, The Netherlands, Denmark, USA and Illumina, Inc., today report the discovery of single-letter variants (SNPs) in the sequence of the human genome associated with high risk of sick sinus syndrome (SSS). The study is published today in the online edition of Nature Genetics. The study reports a genetic variant in the gene MYH6 that is associated with high risk...

2010-12-07 12:31:00

In the news release, New Trial Studies Link Between Stroke and Atrial Fibrillation, issued 07-Dec-2010 by Northwestern Memorial Hospital over PR Newswire, we are advised by the organization that the 11th paragraph, first sentence, should read "If we can monitor more cryptogenic stroke patients for atrial fibrillation beyond the standard time frame..." rather than "...beyond the standard month..." as originally issued inadvertently. The complete, corrected release follows: New Trial Studies...

2010-07-06 13:39:24

Scientists at The University of Manchester have solved a mystery connected with why people die from sudden cardiac arrest during sleep "“ potentially saving thousands of lives. The pioneering research, using detailed computer models, could help save lives through preventative treatment of those most at risk from a form of heart rhythm disorder called sick sinus syndrome. This occurs when the activity of the heart's pacemaker, the sinoatrial node, is impaired. Up to now, no-one has been...

2010-05-12 01:00:00

PARIS, May 12, 2010 /PRNewswire-FirstCall/ -- - New Outcomes Trial to Expand Evidence for Dronedarone in a Different AF Population Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today the initiation of a multinational, randomized double-blind Phase IIIb trial, PALLAS, to assess the potential clinical benefit of Multaq(R) (dronedarone) in over 10, 000 patients with permanent atrial fibrillation (AF) to reduce major adverse cardiovascular events. The announcement was made...

2009-07-28 07:00:00

BRIDGEWATER, N.J., July 28 /PRNewswire-FirstCall/ -- Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today that MULTAQ((R)) (dronedarone) 400 mg Tablets is now available in pharmacies in the United States. MULTAQ is an anti-arrhythmic drug indicated to reduce the risk of cardiovascular hospitalization in patients with paroxysmal or persistent atrial fibrillation (AF) or atrial flutter (AFL), with a recent episode of AF/AFL and associated cardiovascular risk factors (i.e., age...

2009-07-02 10:10:13

The U.S. Food and Drug Administration announced approval Thursday of Multaq tablets to help maintain normal heart rhythms in patients with heart disorders. The FDA said Multaq (dronedarone) is designed to treat atrial fibrillation or atrial flutter in patients whose hearts have returned to normal rhythm or who will undergo drug or electric-shock treatment to restore a normal heart beat. Since Multaq might cause critical adverse reactions, including death, in patients with recent severe heart...

Word of the Day
  • Remarkable; prodigious.
  • Audacious; gutsy.
  • Completely; extremely.
  • Audaciously; boldly.
  • Impressively great in size; enormous; extraordinary.
This word is probably from the dialectal 'boldacious,' a blend of 'bold' and 'audacious.'